Jane Street’s Yarrow Bioscience YARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.7K Sell
819
-1,094
-57% -$35.5K ﹤0.01% 11134
2026
Q1
$57.1K Buy
1,913
+466
+32% +$13.6K ﹤0.01% 10916
2025
Q4
$42K Sell
1,447
-1,495
-51% -$30K ﹤0.01% 10556
2025
Q3
$49.3K Buy
2,942
+446
+18% +$14.6K ﹤0.01% 10358
2025
Q2
$206K Buy
+2,496
New +$162K ﹤0.01% 8494
2025
Q1
Sell
-406
Closed -$68K 10738
2024
Q4
$68K Buy
+406
New +$53.1K ﹤0.01% 8889
2023
Q1
Sell
-21
Closed -$2.77K 10025
2022
Q4
$2.77K Sell
21
-35
-63% -$6.99K ﹤0.01% 8916
2022
Q3
$11K Buy
+56
New +$17.9K ﹤0.01% 9328
2022
Q2
Sell
-13
Closed -$8K 11022
2022
Q1
$8K Sell
13
-15
-54% -$8.91K ﹤0.01% 10097
2021
Q4
$26K Buy
+28
New +$30K ﹤0.01% 9732
2021
Q2
Sell
-19
Closed -$115K 10488
2021
Q1
$115K Buy
+19
New +$138K ﹤0.01% 8582
2020
Q4
Sell
-27
Closed -$164K 8181
2020
Q3
$164K Buy
27
+3
+13% +$17.5K ﹤0.01% 6547
2020
Q2
$148K Buy
24
+10
+71% +$67.7K ﹤0.01% 6560
2020
Q1
$132K Buy
+14
New +$220K ﹤0.01% 4823

Other funds holding YARW

Jane Street's YARW Position: Q2 2026 in Review

Jane Street reduced its Yarrow Bioscience (YARW) stake by 57% in Q2 2026, selling an estimated $35.5K and leaving 819 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #11134.

Jane Street first reported a position in YARW in Q1 2020 and has held it in 14 quarters since. The position peaked at $206K in Q2 2025. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Jane Street held 819 shares of Yarrow Bioscience worth $26.7K as of Q2 2026.
  • Jane Street sold 1,094 Yarrow Bioscience shares in Q2 2026, an estimated $35.5K.
  • Yarrow Bioscience made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11134 holding.
  • Jane Street first reported a position in Yarrow Bioscience in Q1 2020 and has held it in 14 quarters since.
  • Jane Street's Yarrow Bioscience position peaked at $206K in Q2 2025.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.